Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). BD Taps Contract Packager for COVID-19 Test Kits ( MD+DI ).
Let's personalize your content